Stephanie Kreml, M.D., is a Principal at Popper and Company. In her current role, she develops and implements business strategy for start-up companies and new business units in existing companies; consults in areas of clinical need, commercialization, and technology assessment; performs due diligence for investment and acquisition targets in the life science industry; critically evaluates unmet clinical needs and technologies; and provides guidance to accelerate new product development activities.
Latest from Stephanie Kreml
All from Stephanie Kreml
Unlocking Maximum Productivity: AI-Powered Document Redaction & GenAI InnovationAug 30, 2023
Evolution in ITSM: Navigating the New HorizonSep 12, 2023
Cloud Crisis ManagementAug 30, 2023
[Virtual Event] DevSecOps Essentials That Enable Efficient SecuritySep 14, 2023
The State of Data Security and Management: Practical Tips for Building Cyber Resilience Strategies for IT and Security LeadersSep 25, 2023